General Information
Version
1.08
Revision date
2019-07-11
Product name
Hemoglobin A1c Abnormal Control
Icons in SDS
Company Information
company name
DCA Systems
Section 2
Aspiration hazard
Not available. Information on the likely Reconstitution Fluid Not available.
Principle Routes of Exposure
Hemoglobin A1c Normal Control Not available. Hemoglobin A1c Abnormal Control Not available.
Potential Acute Health Effects
Date of issue/Date of revision 11/7/2019 Date of previous issue 76/19/2019 Version 1.08 10/17 DCA Systems HbAi1c Controls
TOXICOLOGICAL INFORMATION
Eye contact Reconstitution Fluid No known significant effects or critical hazards. Hemoglobin A1c Normal Control No known significant effects or critical hazards. Hemoglobin A1c Abnormal Control No known significant effects or critical hazards. Inhalation Reconstitution Fluid No known significant effects or critical hazards. Hemoglobin A1c Normal Control No known significant effects or critical hazards. Hemoglobin A1c Abnormal Control No known significant effects or critical hazards. Skin contact Reconstitution Fluid No known significant effects or critical hazards. Hemoglobin A1c Normal Control No known significant effects or critical hazards. Hemoglobin A1c Abnormal Control No known significant effects or critical hazards. Ingestion Reconstitution Fluid No known significant effects or critical hazards. Hemoglobin A1c Normal Control No known significant effects or critical hazards. Hemoglobin A1c Abnormal Control No known significant effects or critical hazards. Symptoms related to the physical, chemical and toxicological characteristics Eye contact Reconstitution Fluid No specific data. Hemoglobin A1c Normal Control No specific data. Hemoglobin A1c Abnormal Control No specific data. Inhalation Reconstitution Fluid No specific data. Hemoglobin A1c Normal Control No specific data. Hemoglobin A1c Abnormal Control No specific data. Skin contact Reconstitution Fluid No specific data. Hemoglobin A1c Normal Control No specific data. Hemoglobin A1c Abnormal Control No specific data. Ingestion Reconstitution Fluid No specific data. Hemoglobin A1c Normal Control No specific data. Hemoglobin A1c Abnormal Control No specific data. Delayed and immediate effects and also chronic effects from short and long term exposure Short term exposure Potential immediate Reconstitution Fluid Not available. effects Hemoglobin A1c Normal Control Not available. Hemoglobin A1c Abnormal Control Not available. Potential delayed effects Reconstitution Fluid Not available. Hemoglobin A1c Normal Control Not available. Hemoglobin A1c Abnormal Control Not available. Long term exposure Potential immediate Reconstitution Fluid Not available. effects Hemoglobin A1c Normal Control Not available. Hemoglobin A1c Abnormal Control Not available. Potential delayed effects Reconstitution Fluid Not available. Hemoglobin A1c Normal Control Not available. Hemoglobin A1c Abnormal Control Not available. Potential chronic health effects Not available. Conclusion/Summary Not available. Reconstitution Fluid Not available. Hemoglobin A1c Normal Control Not available. Hemoglobin A1c Abnormal Control General No known significant effects or critical hazards. Carcinogenicity May cause cancer. Risk of cancer depends on duration and level of exposure. Date of issue/Date of revision 11/7/2019 Date of previous issue 16/19/2019 Version :1.08 11/17 DCA Systems HbAi1c Controls